Click here to view the United Healthcare (UHC) Medical Policy Updates » December 2024 United…
Humana Medical Policy Updates – June 2019
Click here to view the Humana Medical Policy Updates Updates »
June 2019 Humana Medical Policy Updates;
- Achalasia and Gastroesophageal Reflux Disease (GERD) Treatments
- Airway Clearance Devices
- Athletic Pubalgia Surgery
- Azedra® (iobenguane I 131)
- Bone Density Measurement
- Brachytherapy
- Breast Reconstruction
- Cablivi (caplacizumab‐yhdp)
- Comparative Genomic Hybridization/Chromosomal Microarray Analysis
- Continuous Glucose Monitoring Systems and Insulin Pumps
- Cytological Examination and Fiberoptic Ductoscopy for Breast Cancer Screening
- Drug Testing
- Electrical Stimulation (ES) and Electromagnetic Therapy for the Treatment of Wounds
- Electrical Stimulation (ES) and Electromagnetic Therapy for the Treatment of Wounds
- Elzonris™ (tagraxofusp‐erzs)
- Exhaled Breath Tests
- Gene Expression Profiling
- Gene Expression Profiling
- Genetic Testing for Angelman and Prader-Willi Syndromes
- Genetic Testing for Breast and/or Ovarian Cancer Susceptibility
- Genetic Testing for Cancer Susceptibility
- Genetic Testing for Colorectal Cancer Susceptibility
- Genetic Testing for Diagnosis and Monitoring – Noncancer Indications
- Genetic Testing for Diagnosis and Monitoring – Noncancer Indications
- Genetic Testing for Diagnosis and Monitoring – Noncancer Indications
- Genetic Testing for Ehlers-Danlos Syndrome
- Genetic Testing for Mitochondrial Disorders
- Headache and Occipital Neuralgia Treatments
- Home Oximetry Monitoring
- Hyperhidrosis Treatments
- Hypomethylating agents (azacitidine, decitabine)
- Infertility Evaluation and Treatment
- Infertility Evaluation and Treatment
- IVIG (immune globulin)
- Karyotyping for Diagnosis of Noncancer Indications
- Keratoconus Surgical Treatments
- Libtayo® (cemiplimab‐rwlc)
- Liquid Biopsy
- Low Level Laser Therapy (Cold Laser Therapy), High Power Laser Therapy
- Mobility Assistive Devices (Wheelchairs)
- Molecular Diagnostic Assay and Breath Testing for Transplant Rejection
- Monochromatic Infrared Energy Therapy
- Multianalyte Assays with Algorithmic Analyses (MAAAs)
- Nivestym™ (filgrastim‐aafi)
- Pharmacogenomics and Companion Diagnostics
- Pharmacogenomics and Companion Diagnostics
- Rhinoplasty/Septoplasty
- Serological and Fecal Testing for Inflammatory Bowel Disease (IBD)
- Speech Generating Devices, Voice Prostheses
- Spinal Cord Stimulators
- Tecentriq® (atezolizumab)
- Tilt Table Testing
- Transcatheter Valve Procedures
- Trogarzo™ (ibalizumab‐uiyk)
- Urinary Incontinence Treatments
- Verzenio™ (abemaciclib)
- Whole Genome/Exome Sequencing and Genome-Wide Association Studies
- Whole Genome/Exome Sequencing and Genome-Wide Association Studies
- Zevalin® (ibritumomab)
Click here to view the Humana Medical Policy Updates Updates »
Policy Alerts monitors Commercial and Medicare medical policies for changes. While medical Insurance carriers typically update medical policies annually, there are many reasons why they might review or update a policy. When reviews occur out of cycle they often go unnoticed. Policy Alerts keeps you updated when Payers make coverage changes to medical policies affecting your business.
Policy Alerts continuously monitors Commercial and Medicare Payer coverage information to keep you up-to-date on medical Insurance decisions in real-time. When changes occur, instant email alerts are delivered to your inbox. Clients have access to detailed coverage reports and medical policies through the interactive Policy Alerts Dashboard portal. Save time each month and keep focused on important Payer medical policy reviews and coverage decisions affecting your business!
Policy Alerts takes a client-focused hands-on approach and is constantly working to provide our customers with helpful insights and actionable analytics. We understand what our clients need and are dedicated to providing timely, accurate, and always up-to-date reports.
Health economic and reimbursement information provided by Policy Alerts is gathered from third-party sources and is subject to change without notice as a result of complex and frequently changing laws, regulations, rules and policies. All product and company names are trademarks™ or registered® trademarks of their respective holders. Use of them does not imply any affiliation with or endorsement by them. This information is presented for illustrative purposes only and does not constitute reimbursement or legal advice.
Related Posts
